Navigation Links
Sorrento Announces the Unexpected Death of its Chief Business Officer
Date:7/31/2014

SAN DIEGO, July 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) today announced the death of Mr. Amar Singh, Chief Business Officer and Executive Vice President. Mr. Singh died suddenly and unexpectedly of apparent natural causes on July 30.

"Sorrento is deeply saddened and shocked by the loss of our dear friend and colleague. Our immediate thoughts go to Amar's family and friends," said Henry Ji, Ph.D., Sorrento's President and Chief Executive Officer.

Mr. Singh joined Sorrento in January 2014 from Synta Pharmaceuticals, where he served as SVP and Chief Business Officer since December 2010. Previously, Mr. Singh served as: Chief Operating Officer of Spectrum Pharmaceuticals, where he led the commercial and business development teams; VP and Chief Commercial Officer at Novacea responsible for securing partnerships; and Chief Commercial Officer at Abraxis where he led the launch of Abraxane®. Prior to Abraxis, Mr. Singh held multiple commercial leadership positions in the oncology franchise at Hoffman-La Roche for over 10 years. Mr. Singh holds an M.B.A. from the Stern School of Business at New York University and a B.A. from the University of North Carolina at Chapel Hill.

About Sorrento Therapeutics, Inc.
Sorrento is an oncology company developing new treatments for cancer and associated pain. Sorrento's most advanced asset Cynviloq™, the next-generation paclitaxel, commenced its registrational trial in March 2014 and is being developed under the abbreviated 505(b)(2) regulatory pathway. Sorrento is also developing RTX, a non-opiate TRPV1 agonist currently in a Phase 1/2 study at the National Institutes of Health to treat terminal cancer patients suffering from intractable pain. The Company has made signifi
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor
2. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
3. Sorrento Therapeutics Completes Acquisition of Concortis Biosystems
4. Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
5. Sorrento Therapeutics Adopts Stockholder Rights Plan
6. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
7. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
8. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
9. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
10. Sorrento Therapeutics Completes IgDraSol Merger
11. Sorrento Therapeutics to Present at Two Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Calif. , May 5, 2015  Desert Valley Medical ... times , is the first U.S. hospital to deploy ... Delivery rooms to help reduce the duration of labor and ... is shortened and the risk of caesarean birth is reduced ... However, most mothers in labor are given epidurals and ...
(Date:5/5/2015)... , May 5, 2015  American Laboratory Trading, ... in North America, has named industry veteran Anggie Becorest ... Development. Becorest will be based out of the company,s ... role will include expanding the company,s west coast operations, ... opportunities. "ALT has been the leader in ...
(Date:5/5/2015)... Calif. and ST. LOUIS ... high blood pressure or high cholesterol may achieve better ... performance-based networks, according to early results of a unique ... (NASDAQ: ESRX ). "Pharmacists are one ... their frequent interactions with our members presents enormous opportunities ...
Breaking Medicine Technology:Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4ALT Names Anggie Becorest Senior Vice President of Business Development 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 4
... 11, 2007--New research supported by the,National Institutes ... and Skin Diseases (NIAMS) shows that the,anticonvulsant ... for certain,types of seizures, can be an ... associated with the common, often hard-to-treat,chronic pain ...
... 11 June 2007 - Clavis Pharma (OSE: CLAVIS),presented ... Phase I/II,study with ELACYT in hematologic cancers during ... European Hematology Association (EHA) in,Vienna. ELACYT is a ... hematologic cancers as well as for solid tumours. ...
Cached Medicine Technology:Gabapentin Shown Effective for Fibromyalgia Pain 2Gabapentin Shown Effective for Fibromyalgia Pain 3Clavis Pharma Presented Preliminary Clinical Data on Elacyt at EHA 2
(Date:5/5/2015)... FL (PRWEB) May 05, 2015 ... company focused on the $1.6 billion peripheral nerve repair ... first quarter ended March 31, 2015 compared to $3.14 ... market’s continued adoption of our proprietary portfolio of nerve ... Connector and AxoGuard® Nerve Protector – and our solid ...
(Date:5/5/2015)... PA (PRWEB) May 05, 2015 The 2015 ... raised $110,000 to benefit their global research, outreach and patient ... silent auction, and awards ceremony that attracted hundreds of supporters. ... of the discovery of the hepatitis B virus (HBV) by ... Blumberg received the Nobel Prize in Medicine for his discovery ...
(Date:5/5/2015)... Fla. (PRWEB) May 05, 2015 Baptist ... the Commission on Cancer (CoC) of the American College ... cancer program must meet more than 30 Commission on ... through a survey process, and maintain levels of excellence ... , When patients choose to seek care locally at ...
(Date:5/5/2015)... QuickPick Travel ” was featured on NewsWatch as part of ... and large businesses making an impact in their industry. Susan ... the business review and shared with viewers how this is ... vacation for free. , Vacations are a sought-after opportunity to ... when people are preparing for vacations, they’re used to getting ...
(Date:5/5/2015)... 05, 2015 ProTexting, LLC – ... to deploy Mobile Engagement Campaigns and other Mobile solutions, ... clients can now leverage the power of Mobile Marketing ... syncing subscribers’ e-mail addresses into the Constant Contact Platform. ... that the growing trend of multi-channel marketing would become ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... NUCRYST Pharmaceuticals,Corp. today announced that on September ... & Nephew wound management for the manufacture ... coatings.,The two companies first entered into the ... the Acticoat(TM) brand from NUCRYST and agreed ...
... 1 UTC Power, a,United Technologies Corp. (NYSE: ... Dome- Tech Group, a national energy consulting firm ... Financial terms were not disclosed. Dome-Tech optimizes ... overall efficiency. It facilitates green, sustainable,construction, energy and ...
... Achieve Optimum Health, SOMERSET, N.J., Oct. 1 ... announced that it has launched a fourth business,segment, ... pharmaceutical,companies and healthcare payors achieve the best possible ... and stay on the right therapy, everyone wins ...
... With ... Congressman Rodney Frelinghuysen, PARSIPPANY, N.J., Oct. 1 Daiichi ... rapidly increasing its,staffing since 2002 to support a growing pipeline ... is,one of the few pharmaceutical companies experiencing steady and sustained,growth, ...
... November is Prematurity Awareness Month, WHITE PLAINS, N.Y., ... the March of Dimes to help give,every baby their ... sponsor of the March of Dimes Prematurity Campaign and ... Has a Story",Bus Tour, will raise awareness and fund ...
... "Every school day, 54 million young people attend nearly 123,000 schools, ... to, provide healthy environments could be one of the most ... generation." Former ... President Bill Clinton, SAN DIEGO, Oct. ...
Cached Medicine News:Health News:NUCRYST and Smith & Nephew Revise Agreements 2Health News:NUCRYST and Smith & Nephew Revise Agreements 3Health News:NUCRYST and Smith & Nephew Revise Agreements 4Health News:NUCRYST and Smith & Nephew Revise Agreements 5Health News:NUCRYST and Smith & Nephew Revise Agreements 6Health News:NUCRYST and Smith & Nephew Revise Agreements 7Health News:UTC Power Acquires Dome-Tech Group 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 4Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 6Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 7Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 8Health News:Motherhood(R) Maternity Joins March of Dimes to Give Babies a Healthy Start in Life 2Health News:New Website Launches Healthy Vending in Schools Nationwide to Help Combat Childhood Obesity 2Health News:New Website Launches Healthy Vending in Schools Nationwide to Help Combat Childhood Obesity 3
... EndoProbe handpieces, used ... the ophthamologist with uncompromised ... pathologies. EndoProbe handpieces ... Medical OcuLight green (532 ...
... integrated custom assay service that develops assays for ... of interest, the customer simply provides the samples ... provide a protocol and a Field Applications Specialist ... the laboratory. This will help reduce labor costs ...
... The Medical Imaging Consultant, PDA Edition ... fellows who may order diagnostic imaging studies. ... device to extensive information that will help ... based on symptoms, and which studies will ...
The Perkins has been established for well over 20 years as a "world standard" for hand held applanation tonometers....
Medicine Products: